12:00 AM
 | 
Mar 16, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

SCH 900795: Phase I started

Schering-Plough began a double-blind, placebo-controlled, single ascending-dose, Belgian Phase I trial to evaluate intranasal SCH 900795 in 120...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >